BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6794141)

  • 1. Hematologic and cytogenetic effects of androgens in cytostatic-treated mice (the micronucleus test).
    Ioan D
    Endocrinologie; 1981; 19(3):179-81. PubMed ID: 6794141
    [No Abstract]   [Full Text] [Related]  

  • 2. The mutagenic effect of 131I and of two cytostatics revealed by the micronucleus test (MT).
    Ioan D; Petrescu M; Maximilian C
    Endocrinologie; 1977; 15(2):119-22. PubMed ID: 405734
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleus anomaly test and chromosomal analysis of bone marrow cells of the Chinese hamster and dominant lethal test in male mice after treatment with fluorescent whitening agents.
    Müller D; Fritz H; Langauer M; Strasser FF
    Environ Qual Saf Suppl; 1975; 4():247-63. PubMed ID: 1064545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological aspects of the action of antimitotic drugs on the reticuloendothelial system: the giant histiocytic cells].
    Castaldi G; Zavagli G; Fiocchi O; Trotta F
    Haematologica; 1969; 54(5):297-317. PubMed ID: 4993365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disturbances of mitotic activity in hemohistoblasts of the bone marrow during acute radiation injury and under the effects of chemical mutagenic agents].
    Gol'dberg ED; Gol'dberg DI; Golubev IV
    Arkh Patol; 1967; 29(2):25-30. PubMed ID: 4973501
    [No Abstract]   [Full Text] [Related]  

  • 7. [The cytogenetic effects of antitumor preparations with different mechanisms of action].
    Khlusova MIu; Novitskiĭ VV; Gol'dberg ED
    Eksp Klin Farmakol; 1992; 55(2):49-52. PubMed ID: 1422456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cytogenetic screening for determination of the mutagenic potential of cyclophosphamide.
    Barbărasă C; Luca D; Postică F; Covic M
    Morphol Embryol (Bucur); 1979; 25(4):369-72. PubMed ID: 160994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior of marrow stem cells in irradiated and non-irradiated mice after treatment with cytotoxic agents.
    Berman I; McCabe B; Dauer MM
    Radiat Res; 1969 May; 38(2):296-306. PubMed ID: 4977149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of combined cytoxic agents on the bone marrow].
    Maisin H
    C R Seances Soc Biol Fil; 1966; 160(8):1740-4. PubMed ID: 4227904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the bone marrow cell count of mice under the combined action of ultrahigh-frequency irradiation and of antitumor preparations].
    Sevast'ianova LA; Vilenskaia RL; Kubatkina EI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 0(8):55-7. PubMed ID: 4138941
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro.
    Brown CH; Carbone PP
    Cancer Res; 1971 Feb; 31(2):185-90. PubMed ID: 5545269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of claphene on marrow cell chromosomes in golden hamster (Mesocricetus auratus) in vivo].
    Constantinescu O; Iliescu A
    Arch Roum Pathol Exp Microbiol; 1971; 30(3):485-91. PubMed ID: 5150509
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten model mutagens evaluated by the micronucleus test.
    Maier P; Schmid W
    Mutat Res; 1976 Nov; 40(4):325-37. PubMed ID: 64925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.
    Xu Y; Hansen WK; Rosenquist TA; Williams DA; Limp-Foster M; Kelley MR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):825-31. PubMed ID: 11181913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary assessment of the cytogenetic effects of metepa on mouse bone marrow using the micronucleus test.
    Richardson JC
    Mutat Res; 1974 Oct; 26(5):391-4. PubMed ID: 4411711
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells.
    Martinova Y; Topashka-Ancheva M; Konstantinov S; Petkova S; Karaivanova M; Berger M
    Arch Toxicol; 2006 Jan; 80(1):27-33. PubMed ID: 16079990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.